Reviewer comment: While there were fewer dose holds and dose reductions in the Loperamide Cohort of Study 6201 compared to patients in Study 3004, there remained a substantial rate of treatment discontinuations despite antidiarrheal prophylaxis with loperamide. The rates of hospitalization are similar between the cohorts.